SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma informs about disclosure

10 Mar 2022 Evaluate
Anuh Pharma has informed that the for the time being it is withdrawing the application for Direct Listing of 5,01,12,000 Equity Shares of Rs 5.00 each fully paid up of the Company on NSE and the Company shall re-apply for the same in due course of time. The intimation letter to NSE has been attached as Annexure - 1.

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×